Morgan Stanley on Adani Energy Solutions
Recommendation: Buy, Target: ₹1,567
The new order win is estimated at Rs 4,300 cr and takes the transmission capex portfolio to Rs 91,500 cr.
This will add Rs 500 cr in annual tariffs once commissioned.
It also adds 881 ckm of transmission lines and 3,160 MVA of transformation capacity to the portfolio.
The deal includes 2.4 GW from Adani Power’s upcoming Pirpainti thermal plant.
Completion is targeted for 4QCY28.
Morgan Stanley on Asian Paints (APAC Meet)
In FY27, decorative industry volumes are expected to grow 6 to 7%.
The company is growing ahead of the industry and expects momentum to continue in H2.
It has taken a ~15% cumulative price increase against ~28% cost inflation.
Focus remains on maintaining EBITDA margin between 18% and 20%.
The company has been gaining share recently through initiatives, product innovation, and dealer engagement.
Morgan Stanley on Bajaj Finance
Recommendation: Overweight, Target: ₹1,290 (Earlier Target: ₹1,260)
The revision factors in the company’s ₹175 billion capital raise, comprising a ₹117 billion QIP and a ₹58 billion preferential issue by the promoter.
PAT estimates for FY27, FY28, and FY29 have been raised by 0.9%, 2.4%, and 2.5%, respectively.
EPS estimates increase only 0.1 to 0.6% because of the higher share count following the fundraise.
Book value per share estimates are raised by 6.7 to 7.9% over FY27 to FY29.
Bull-case valuation is raised to ₹1,620 and bear-case valuation to ₹880, while leaving operating assumptions unchanged.
Morgan Stanley on InterGlobe Aviation
Recommendation: Overweight, Target: ₹6,490
Sees early signs of a turnaround in the airline downcycle.
Management has reiterated its guidance for Q3 passenger revenue per available seat kilometre (PRASK) growth of over 25%.
Cost per available seat kilometre (CASK), excluding fuel and forex, is expected to rise in the high-single-digit to low-double-digit range.
Around half of non-fuel CASK is USD-denominated, making rupee appreciation a potential positive for the revenue-cost spread.
Sees medium-term non-fuel CASK inflation moderating to the mid-single digits.
Believes jet fuel cost pressures may have peaked and expects aircraft capacity growth to return to the mid-teens in FY28 under normal conditions.
Morgan Stanley on Maruti Suzuki (APAC Meet)
Recommendation: Overweight, Target: ₹14,560
Bullish on demand, with recovery being broad-based and rural doing better than urban.
Post-Diwali bookings are up 20% YoY and bookings remain ahead of supply.
Management reiterated its double-digit H2 volume growth guidance.
The company will take a calibrated price hike.
Morgan Stanley on Nykaa (APAC Meet)
Bullish on India’s premium consumption opportunity across beauty and fashion.
Consolidated EBITDA margins are expected to improve to low to mid-teens by FY2030.
Beauty is seeing healthy growth trends across customer frequency and basket size.
Fashion margin is expected to improve to a high-single-digit EBITDA margin.
Very optimistic about the opportunity for the house of brands.
Partnership with Nike and new brand additions, including H&M, have been performing well.
Morgan Stanley on Phoenix Mills
Category mix, with jewelry and electronics being better, explains part of the slower rental growth.
Palladium Mumbai 0.5 msf expansion is expected in FY28.
Renovation and tenant changes are driving Pune’s Avenue of Stars growth.
Hotel brands under discussion include St. Regis in Lucknow and JW Marriott in Coimbatore.
Expects ~Rs 12,500 cr of operating cash flow over five years.
This should support development, acquisitions, and CPP (Canada Pension) stake purchases.
Morgan Stanley on Shadowfax
Management reiterated its revenue CAGR guidance of 27 to 30% over the medium term.
Growth momentum in express is seen holding up well, supported by D2C, new customer wins, and new offerings such as Prime Large.
Hyperlocal growth momentum is seen continuing as well.
Key for margin improvement will likely be service EBITDA margins in H2 and FY28.
Expects strong operating leverage over the periods.
Morgan Stanley on corporates – APAC Meet
Shriram Finance sees an opportunity to scale the MSME loan book to Rs 1 trn over the next four years.
ICICI Bank noted corporate borrowing is shifting to banks, although this could reverse if bond yields decline.
Swiggy is focusing on improving burn in the quick commerce business with no material store or network expansion plans.
Tata Consultancy Services indicated that demand is largely stable, with deflationary pressures expected to ease and new services continuing to grow rapidly.
Hexaware Technologies highlighted that AI for IT is driving significant productivity benefits, while AI for business is likely to offset it and drive incremental revenue opportunities.
Jefferies on Paytm and Pine Labs
Media reports suggest the government may defer the rollout of MDR on UPI until state elections.
In 2027, five states go to the polls in Feb to Mar 2027, and if all goes as planned, results will be out by Mar to Apr.
In the base case, MDR on UPI forms 8 to 12% of FY27 EPS with a 4Q rollout, and 28% of PBT in FY28 on a full-year basis for both Paytm and Pine Labs.
The news report puts risk on FY27 estimates, though if implemented right after elections, the risk may be lower.
Stocks may see an overhang until clarity emerges.
MDR contributes ~12% of FY27E PBT for Paytm and ~8% for Pine Labs.
Nomura on One 97 Communications (Paytm)
Recommendation: Buy, Target: ₹2,300
Paytm has approved a partnership with Funding Asia Group for its Singapore expansion.
Paytm Singapore will invest up to INR 2 bn in Funding Societies’ subsidiaries, out of the INR 5 bn earlier invested by Paytm in Paytm Singapore.
Of this, about INR 1.6 bn (SGD 21.8 mn) is an all-cash investment for a 19.1% stake in CardUp Pte. Ltd., its Singapore digital payments arm.
The remaining INR 0.38 bn may go into another Funding Societies affiliate.
The deal is subject to due diligence, corporate approvals, and definitive agreements, and is expected to close by 20 May 2027.
The investment is small relative to Paytm’s balance sheet and is unlikely to change its financials materially in the near term.
Views it as a low-cost way to enter the Singapore market.
Axis Capital on Cement (AP & Telangana Dealer Call)
Demand remains healthy in the region.
Cement prices have risen Rs 20 to 25 per bag from the lows at the end of August.
A Rs 20 per bag hike attempted in November was not successful, and another price hike attempt is likely in December.
UltraTech is commanding a Rs 45 to 50 per bag trade premium over ACC, Ambuja, and Ramco.
Regional players are increasingly prioritizing profitability over volume.
Prefers UltraTech in large caps and JK Cement in mid-caps.
Axis Capital on Ceramics (Dealer Check)
The domestic tiles market is growing 5 to 7%.
The exports market is expected to shrink 40 to 45% this year due to high freight costs.
Utilization at Morbi hence remains 20 to 23% below pre-West-Asia-crisis levels.
Price hikes of 15 to 16% by branded players have been broadly maintained.
Gas prices remain high and demand remains supportive.
Larger players like Kajaria and Somany will likely achieve high-single to low-double-digit growth, aided by a seasonally stronger H2, domestically preferred product portfolios, strong dealer relationships, and healthy underlying demand.
Citi on Vedanta
Recommendation: Sell, Target: ₹210 (Earlier Target: ₹235)
The commodities team sees the physical zinc market as relatively balanced into 2027, with risks skewing towards moderation of elevated positioning due to tepid longer-term structural demand exposure, risk of mine supply easing, and LME premium over SHFE easing.
Citi LME zinc estimate for CY28 is $3,700 against spot of $3,550.
Silver accounts for 40% of attributable EBITDA, with upsides likely predicated on easing macro conditions.
Incorporates silver prices at $60/oz in FY28 compared to spot of $45/oz.
Every $100/t change in zinc-lead LME impacts EBITDA by 4% and fair value by Rs 12/share, while a $10/oz change in silver impacts EBITDA by 7% and fair value by Rs 16/share.
Cash use concerns remain as Vedanta Ltd is not bound by its old dividend policy.
Volume growth in HZL is likely only in 2HFY29, though Zinc International should benefit from Gamsberg Phase 2.
FY28E attributable EBITDA breakup is HZL 81%, Zinc International 16%, and others 4%.
CLSA on Global Price Action
India retains the strongest structural setup and the Nifty remains the standout major regional market.
The breakout above 24,526 to 24,872 keeps the immediate bias positive.
Maintains the setup for an eventual break above 26,000 to 26,300.
A confirmed breakout would support an upside target of 31,600 to 31,700.
CLSA on LG Electronics (India Forum)
Recommendation: Outperform, Target: ₹1,865
Sees robust demand, continued premiumization, and strong market positioning across key categories.
Normalised AC inventories provide a near-term catalyst.
Sri City, growing exports, and the planned vehicle-solutions business should broaden the medium-term growth opportunity.
Pricing and localisation remain key levers against commodity inflation.
Royalty rates to the parent company are expected to remain stable in the near term.
Elara Capital on India FMCG
Sees resilient FMCG demand in H1FY27, supported by GST rate cuts, with weighted average volume growth at around 9%.
Rural demand continues to outperform urban demand, although a deficient monsoon and crude prices up 35% YoY pose risks to FY28 growth.
Expects the growth outlook to improve from H2FY28, but believes a sustained sector re-rating depends on a revival in double-digit earnings growth.
FMCG sector valuations have derated 20% since FY19, while gross profit growth has been weak, with gross margins contracting 177 bps over FY21 to FY26.
Adds Varun Beverages to its preferred list and continues to favour Marico, Tata Consumer Products, and Nestlé.
A return to double-digit gross profit growth is seen as the key trigger for the sector’s next re-rating.
Elara Capital on India Utilities
Believes the recent valuation reset has created a compelling buying opportunity in the utilities sector, with NTPC, NLC India, Adani Energy Solutions, and CESC down 20 to 40% over six months.
Power demand is projected to grow at a 5 to 6% CAGR over FY27 to FY36, while FY27-to-date electricity generation is up 11.6% YoY.
Peak power demand has risen to 271 GW from 135 GW over FY13 to FY27, with the CEA projecting 459 GW by FY36.
Solar and wind account for around 41% of installed capacity, although coal remains the largest source at 231 GW.
Sees opportunities in battery storage, pumped storage, data centres, green hydrogen, and nuclear energy.
Cites rising demand, earnings visibility, and capacity additions as reasons the sector offers an attractive entry point.
Goldman Sachs on Garden Reach Shipbuilders & Engineers
Recommendation: Sell, Target: ₹1,735
Revenue contribution from NGC is likely to commence only from FY29.
Expects margins in Q3FY27 to be robust at 13.1%.
In the medium term, management remains optimistic on the order pipeline.
Uncertainties around order finalisation and execution timelines could limit near-term revenue visibility.
Remains cautious on the potential execution gap between existing and upcoming projects.
HSBC on Agri-Inputs
Expects a muted 2HFY27 for agro-chemical players, though sector valuations have turned attractive.
Highlights rising macro challenges in Maharashtra and Karnataka, while North India macros remain stable.
Outlook is concerning as Rabi sowing trails at 11% YoY and water reservoir levels remain low.
Crop prices have risen 15 to 70%.
Maintains Buy on UPL, Bayer CropScience, Dhanuka, and Rallis India.
HSBC on Consumer Staples
Recommendation: Buy, Target: ₹1,210
Conducted an analysis of the international portfolios of TCPL, Marico, Dabur, and GCPL.
Marico again stands out on growth, margins, and RoCE, with its international business acting as a driver and not a drag on growth or returns.
Implied India business multiple is highest for Tata Consumer even as target multiples remain blended.
HSBC on Onemi Tech
Recommendation: Buy, Target: ₹500
Initiates coverage with a Buy rating.
KISSHT belongs to a handful of companies in India with a differentiated and digital unsecured lending model.
Rapid scale-up off a low base, efficiency gains, and controlled credit costs are expected to drive ~60% PAT CAGR over FY26 to FY29E.
Values the stock at an implied P/B of 2.2x FY28E BVPS.
Jefferies on Whirlpool India
Recommendation: Hold, Target: ₹875 (Earlier Target: ₹835)
New energy regulations and product launches have fueled costs.
The company has taken a 5% price hike effective 1 November to mitigate costs.
Elica, which forms 7% of sales in the kitchen mix, is growing well.
Whirlpool is now ranked number 2 in both Direct Cool Refrigerators and Semi-Automatic Washers.
Cuts FY27E EPS but retains FY28 to FY29E estimates.
The parent company now holds a ~40% stake, and any change will be monitorable.
JPM on Cyient
Recommendation: Overweight, Target: ₹1,300
Cyient announced that its semiconductor business has approved a strategic investment of $10 mn by GlobalFoundries at the same valuation of $0.5 bn at which EAAA India Alternatives made its $10 mn equity investment in May 2026.
Does not assign any value to the semiconductors business in SOTP given it is currently loss-making.
Cyient’s current market cap is $1.2 bn, of which $295 mn comes from its stake in DLM.
Ascribing a $490 mn valuation for semiconductors per the recent transaction implies a core DET value of only $480 mn, or 6x FY28 PE, which represents deep value.
JPM on Eicher Motors
Recommendation: Overweight, Target: ₹8,750
Management remains focused on volume growth being the main driver of earnings rather than margin percentage.
Exports can be a strong engine of growth with Brazil as the anchor market.
Developed markets are showing early green shoots, while ASEAN is a slow market-building exercise.
Royal Enfield is stepping up capacity to ~2 mn by 2QFY28 and ~2.45 mn by FY29 to FY30, with supply chain ramp-up as the key focus area.
Eicher Motors plans to follow the EV transition rather than lead it, with Flying Flea serving as a showcase brand not expected to add meaningful volumes in the near term.
JPM on Paints
Spoke to over 35 paint dealers across the country to assess demand trends during the Oct to Nov 2026 period.
Post a healthy offtake in October due to the festive shift, demand moderated in November.
Paint companies remain constructive on H2, supported by a favourable wedding and festive calendar, resilient rural demand, and healthy project demand.
Inflationary impact and potential softening in rural demand amid a weak monsoon remain key monitorables.
Margins should improve sequentially through H2, though still decline on a YoY basis as pricing catches up with earlier raw-material inflation, with crude and derivative prices remaining key monitorables.
Asian Paints’ Q2 outperformance versus industry peers highlights its superior on-ground execution, aided by focused interventions and a targeted region and market-specific approach.
Remains Overweight on Asian Paints and Pidilite.
Kotak on TCS
AI-led revenue deflation will continue.
AI revenue pace should moderate after the first round of productivity pass-through.
More than half of its top 200 customers have already gone through AI efficiency-led renegotiations.
Growth can accelerate as the incremental deflationary drag moderates.
Investments in capabilities, partnerships, and new adjacencies are contributing.
Medium-term margin aspirations remain unchanged despite near-term headwinds.
Macquarie on Pharma
Double upgrades Max Healthcare and Apollo Hospitals to Outperform.
Believes consensus earnings have bottomed out and valuations have cooled off.
The initial profitability drag from the bed expansion cycle is already embedded, and new capacity is ramping up at a healthy pace.
Raises Max Healthcare target price to ₹1,450 and Apollo Hospitals target price to ₹10,500.
Believes Max Healthcare offers a better risk-reward profile.
Motilal Oswal on Tata Technologies
Recommendation: Sell, Target: ₹630
Implies an 11% downside from the stated market price of ₹704.
The target is based on 26x FY28E EPS, while the stock trades at around 30x FY28E EPS.
At current valuations, Tata Technologies commands an approximately 85% premium to KPIT Technologies and a 20% premium to Tata Elxsi.
Management is targeting revenue of $1.1 to 1.3 billion by FY30, but the brokerage wants to see execution evidence before turning positive.
Aerospace revenue is targeted to reach a $100 million exit run-rate by FY28.
The company aims to expand operating EBITDA margins from 15.5% in FY26 to over 20% by FY30, though Motilal Oswal maintains its cautious stance.
Nomura on Alkem Labs
Recommendation: Buy, Target: ₹6,800
The Daman site has been issued a warning letter, though earnings impact is expected to be limited and the stock has already underperformed since OAI classification.
Issuance of a warning letter is an escalation suggesting the FDA is likely not satisfied with the response following Form 483.
Resolution could take up to 24 months.
Daman contributes 45% to the company’s US revenues, and in a worst-case import alert scenario, FY28 to FY29F earnings impact could range from 10 to 15%.
Does not expect an import alert.
Believes the FDA action is priced in as Alkem is down 10% since 6 August 2026 when the Daman site was classified as OAI, compared to Nifty up 3.6% and Nifty Pharma up 6.8%.
UBS on Midcap
Seeking bottom-up outperformance with earnings visibility and company-specific catalysts.
Picks have potential for earnings surprise.
Top picks include Shaily Engineering, Indian Hotels, Shyam Metalics, CarTrade, Dr. Lal PathLabs, Max Healthcare, MCX, and APL Apollo.







Leave a Reply